AXA Reports Steady Growth with a 7% Revenue Increase

image

AXA Reports Steady Growth with a 7% Revenue Increase

In the latest earnings announcement, AXA Group CEO Thomas Buberl presented a strong financial report for the first nine months of 2024, showing a 7% increase in total revenues across various business sectors. Both the Property & Casualty (P&C) and Life and Health sectors experienced a 7% rise in revenue; disciplined pricing and enhanced customer loyalty contributed to this growth. AXA also maintained a strong capital position with a Solvency II ratio of 221% and expects a fundamental earnings per share (EPS) growth between 6% and 8% for the year, in line with its three-year plan.

Key Highlights:

  • AXA's total revenues increased by 7%, with equal growth seen in both the P&C and Life and Health sectors.
  • The company's Solvency II ratio is strong at 221%.
  • Expected fundamental EPS growth between 6% and 8% aligns with AXA's three-year plan.
  • AXA has observed disciplined pricing and enhanced customer loyalty, particularly in commercial lines.
  • Life premiums rose by 7%, supported by strong sales in Japan and Italy.
  • Year-to-date net flows reached €0.9 billion, marking a significant turnaround from negative flows the previous year.
  • AXA expects to achieve a 200-basis-point improvement in the P&C combined ratio.
  • Notable growth in Health premiums outside of Europe, with significant increases seen in Mexico and Turkey.

Company Outlook:

  • AXA anticipates continuous fundamental EPS growth within a target range of 6% to 8% for 2024.
  • The company expects to reach the upper end of its capital generation guidance of 25 to 30 points.
  • The UK Health segment is projected to return to profitability by 2025.

Negative Highlights:

  • A 50-basis-point decline in the NBV margin, mainly due to business mix and financial assumptions.
  • A concerning €600 million net outflow in Unit-Linked products.
  • Although sales in France increased significantly, margins were slightly lower.

Positive Highlights:

  • Strong Health premium growth in Mexico and Turkey, with a 15% rise in Mexico and nearly a doubling in Turkey.
  • The company feels secure in achieving its growth target for P&C, projecting 4-5% growth by 2025.
  • Accident insurance pricing is accelerating in the U.S., with property prices rising by 7-8%.

Shortcomings:

  • Despite overall growth, high-margin sales in Switzerland and Japan declined.
  • The second half of the year typically sees lower capital generation performance.

Q&A Highlights:

  • AXA expects a €100 million impact from a 25-basis-point drop in discount rates, provided interest rates remain stable.
  • The company is increasing internal reinsurance in its P&C business to optimize capital.
  • Six-month assessments for accident reserves did not reveal any issues.
  • Damages from Hurricanes Helene and Milton are estimated at €200 million.
  • AXA does not undertake life and health reinsurance, focusing solely on P&C.
  • Discussions regarding potential integration with Monte dei Paschi may occur after the joint venture agreement expires in 2027.
  • Despite the upcoming sale of its asset management unit, AXA IM maintained all clients, although third-party net inflows were lower.

AXA (ticker: AXA), under the leadership of Group CEO Thomas Buberl, has demonstrated a consistent and disciplined approach to growth, as reflected in its most recent earnings announcement. The company’s strategic focus on pricing, customer loyalty, and diversified business lines contributes to a positive financial outlook with expectations of continuous EPS growth and strong capital generation. Despite challenges such as lower margins in some areas and net outflows in Unit-Linked products, AXA remains confident in meeting its long-term objectives and maintaining its position as a leading global insurer.

InvestingPro Forecasts: AXA's recently reported strong financial performance is further supported by data from InvestingPro, showing the company's market capitalization reaching an impressive $78.7 billion, reflecting its significant presence in the insurance sector.

One of InvestingPro's insights highlights that AXA has maintained uninterrupted dividend payments for 45 years, showcasing its commitment to shareholder returns and financial stability. This aligns with the company’s reported strong Solvency II ratio of 221% and the expected fundamental EPS growth of 6% to 8%.

The company’s price-to-earnings (P/E) ratio of 10.6 suggests that AXA shares may be undervalued relative to their earnings potential. This is particularly interesting when considered alongside another InvestingPro insight indicating that AXA has been trading at a low P/E ratio based on its near-term earnings growth. This could be an attractive point for investors, given the company's anticipated growth and strong market position.

As of the second quarter of 2024, AXA's trailing twelve-month revenue reached $97 billion, recording a growth rate of 6.25%. This is consistent with the reported 7% increase in total revenues, demonstrating consistent growth across different reporting periods.

It is worth noting that InvestingPro offered eight additional insights on AXA, providing investors with a more comprehensive view of the company’s financial health and market position.

Despite the strong performance highlighted in the earnings announcement across various sectors, an InvestingPro insight points out that AXA suffers from weak gross profit margins. This is reflected in a gross profit margin of 15.1% for the trailing twelve months as of the second quarter of 2024. However, this should be evaluated in the context of typical margin structures within the insurance sector.

Overall, the data and insights from InvestingPro complement the earnings announcement information, offering a more holistic view of AXA's financial condition and market performance. These forecasts reinforce the company’s strong market presence and ongoing growth potential while also highlighting areas that investors may want to monitor closely.